Severe Neurological Decompression Sickness in a U-2 Pilot

99th Reconnaissance Squadron, Beale Air Force Base, CA 95903, USA.
Aviation Space and Environmental Medicine (Impact Factor: 0.88). 01/2010; 81(1):64-8. DOI: 10.3357/ASEM.2303.2010
Source: PubMed


Severe neurological decompression sickness (DCS) has been a rare entity in the U.S. Air Force, including the U-2 community. In over 50 yr of operation, few U-2 pilots reported severe neurological DCS in flight despite the extreme altitudes at which they operate. This article describes a near-fatal case of neurological DCS that occurred during a combat mission. The injury left the pilot with permanent cognitive deficits that correlated with focal lesions present on magnetic resonance imaging of his brain. To our knowledge, the images presented herein are the first to show radiological evidence of brain injury induced by altitude DCS. Though only a single case, the objective and clinical findings in the case pilot are similar to results documented in divers suffering DCS with central nervous system injury and victims of traumatic brain injury. DCS will remain a potentially serious threat to current and future air and space operations.

Download full-text


Available from: Sean L Jersey, Sep 04, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Decompression illness is caused by intravascular or extravascular bubbles that are formed as a result of reduction in environmental pressure (decompression). The term covers both arterial gas embolism, in which alveolar gas or venous gas emboli (via cardiac shunts or via pulmonary vessels) are introduced into the arterial circulation, and decompression sickness, which is caused by in-situ bubble formation from dissolved inert gas. Both syndromes can occur in divers, compressed air workers, aviators, and astronauts, but arterial gas embolism also arises from iatrogenic causes unrelated to decompression. Risk of decompression illness is affected by immersion, exercise, and heat or cold. Manifestations range from itching and minor pain to neurological symptoms, cardiac collapse, and death. First-aid treatment is 100% oxygen and definitive treatment is recompression to increased pressure, breathing 100% oxygen. Adjunctive treatment, including fluid administration and prophylaxis against venous thromboembolism in paralysed patients, is also recommended. Treatment is, in most cases, effective although residual deficits can remain in serious cases, even after several recompressions.
    The Lancet 01/2011; 377(9760):153-64. DOI:10.1016/S0140-6736(10)61085-9 · 45.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gyroscope-like microparticle of lithium iron phosphate/multiwalled carbon nanotubes composites is synthesized by microwave-assisted sol–gel method with ferrous oxalate, lithium carbonate, and ammonium dihydric phosphate as raw materials. This new composites with gyroscope-like have not been reported in the literature. The crystal structure and surface morphology of the as-prepared particles are characterized by X-ray diffraction and transmission electron microscopy tests, and their electrochemical properties are investigated by cyclic voltammetry and galvanostatic charge/discharge tests. The results demonstrated that the composites have an olivine structure and superior electrochemical performances in terms of discharge capacity, cycling stability and rate capability. These favorable electrochemical properties should be attributed to its special gyroscope-like microstructure.
    Synthetic Metals 03/2011; 161(5):548-551. DOI:10.1016/j.synthmet.2011.01.008 · 2.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Compared to the previous 47 yr, U-2 pilots reported an increased number of altitude decompression sickness (DCS) incidents with central nervous system (CNS) manifestations during 2002-2009. Due to increasing incident severity during military operations, the U.S. Air Force initiated an investigation to prevent future mishaps. We retrospectively examined all neurological DCS cases observed among U-2 pilots during 2002-2009. Urgency to prevent further pilot losses limited this study to using existing, often incomplete data sources. During 2002-2009, 16 confirmed incidents of CNS DCS occurred with 13 pilots, plus 4 possible incidents with 4 pilots. Significantly, 12 of 16 confirmed incidents occurred at 1 operating location, including 4 of 5 life-threatening cases. This series of cases were of a type and severity rarely found in flight operations and correlated temporally with increased sortie frequency/duration associated with combat operations. Multiple investigations confirmed no defects in aircraft, support equipment, or oxygen supplies. Nor were significant trends observed with age, habitus, environmental exposure, medication use, or cardiac defects. In 11 cases, symptom recognition occurred well after the 4-h point where clinical experience indicated risk should stabilize. Symptoms also recurred days later and responded to repeat hyperbaric oxygen therapy in three of four cases. Finally, neuropsychiatric symptoms persisted in six pilots for years and may represent permanent injury. An increase in U-2 CNS DCS cases probably resulted from more cockpit activity combined with longer, more frequent high-altitude exposures. Adjustments in preoxygenation, cabin altitude, exercise at altitude, and frequency of flights may reduce incidence.
    Aviation Space and Environmental Medicine 07/2011; 82(7):673-82. DOI:10.3357/ASEM.2851.2011 · 0.88 Impact Factor
Show more